Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer

Código QR

Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer

Therapeutics: Dual therapy shrinks triple negative breast tumors Two experimental drugs currently in clinical trials as single agents might work better together against triple negative breast cancer. Jeffrey Solzak and Milan Radovich, and colleagues from the Indiana University School of Medicine in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jeffrey P. Solzak, Rutuja V. Atale, Bradley A. Hancock, Anthony L. Sinn, Karen E. Pollok, David R. Jones, Milan Radovich
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/4e107a1dad504786a827e6d2492a7acf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
por: Yu-Hsiang Chen, et al.
Publicado: (2017)

Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer
por: Mirjana Prvanović, et al.
Publicado: (2021)

Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis
por: Zou H, et al.
Publicado: (2016)

Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner.
por: Nandini Dey, et al.
Publicado: (2013)

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
por: Guru Sonpavde, et al.
Publicado: (2021)

Synergistic effects of concurrent blockade of PI3K and MEK pathways in pancreatic cancer preclinical models.
por: Hua Zhong, et al.
Publicado: (2013)

Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ
por: Mayuko Uehara, et al.
Publicado: (2017)

Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis
por: Hu Y, et al.
Publicado: (2021)

TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration
por: Wardhani BWK, et al.
Publicado: (2021)

Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses
por: Ranjna Madan-Lala, et al.
Publicado: (2017)

Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs
por: Cholpon S. Djuzenova, et al.
Publicado: (2021)

INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer
por: Samuel J. Rodgers, et al.
Publicado: (2021)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner J, et al.
Publicado: (2015)

TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism
por: Jie Cheng, et al.
Publicado: (2020)

A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer
por: Li X, et al.
Publicado: (2020)

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
por: Wen-Hung Kuo, et al.
Publicado: (2012)

The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells
por: Ian J. Huggins, et al.
Publicado: (2017)

Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
por: Zhonghe Zhao, et al.
Publicado: (2021)

Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits
por: Chiara Giacomelli, et al.
Publicado: (2021)

BRCA2 mutations and triple-negative breast cancer.
por: Peter Meyer, et al.
Publicado: (2012)

Triple-negative breast cancer: treatment challenges and solutions
por: Collignon J, et al.
Publicado: (2016)

Opportunities for metastatic triple negative breast cancer therapy
por: Inna P. Ganshina, et al.
Publicado: (2021)

Antiangiogenic therapy for breast cancer with triple negative phenotype
por: Inna P. Ganshina, et al.
Publicado: (2021)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Paolo Peterlongo, et al.
Publicado: (2021)

Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines
por: I-Lun Hsin, et al.
Publicado: (2021)

Single-Layered Flexible Dual Transmissive Rasorbers With Dual/Triple Absorption Bands for Conformal Applications
por: Mehran Manzoor Zargar, et al.
Publicado: (2021)

Novel Dual PI3K/mTOR Inhibitor, Apitolisib (GDC-0980), Inhibits Growth and Induces Apoptosis in Human Glioblastoma Cells
por: Wioleta Justyna Omeljaniuk, et al.
Publicado: (2021)

Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
por: Jochen Schulze, et al.
Publicado: (2010)

The Wnt receptor Ryk is a negative regulator of mammalian dendrite morphogenesis
por: Vanessa Lanoue, et al.
Publicado: (2017)

Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype
por: Marina K. Ibragimova, et al.
Publicado: (2021)

Molecular heterogeneity in adjacent cells in triple-negative breast cancer
por: Huebschman ML, et al.
Publicado: (2015)

The co-treatment of rosuvastatin with dapagliflozin synergistically inhibited apoptosis via activating the PI3K/AKt/mTOR signaling pathway in myocardial ischemia/reperfusion injury rats
por: Gong Lei, et al.
Publicado: (2020)

Modulation of telomere protection by the PI3K/AKT pathway
por: Marinela Méndez-Pertuz, et al.
Publicado: (2017)

Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
por: Fan Yang, et al.
Publicado: (2021)

Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel–cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines
por: Ye J, et al.
Publicado: (2016)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Anna E. M. Bastiaansen, et al.
Publicado: (2020)

Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells
por: YoungJun Ju, et al.
Publicado: (2021)

Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
por: L. E. Anselmino, et al.
Publicado: (2021)